STAT

NOVEMBER 18, 2023

Jennifer Doudna and Emmanuelle Charpentier, now Nobelists , published their first paper announcing a new enzyme for editing DNA in Science in June 2012. The revolution started in silence. It was called CRISPR-Cas9.

358

358

Outsourcing Pharma

MARCH 20, 2023

Despite diversity being spoken about more than ever before, research discovers clinical trials are less representative of the US population compared to a decade prior.

64

64

STAT

SEPTEMBER 18, 2023

more than doubled from 1991 and 2012 and has continued to grow steadily in the years since. The number of credentialed midwives — including both certified nurse-midwives, who can attend births in hospital settings, and a minority of certified midwives, who don’t hold a nursing degree — in the U.S.

Hospitals 363

Hospitals 363

STAT

JULY 18, 2023

But many immigrants don’t have access to this coverage, making them more vulnerable to maternal health problems, as highlighted by a new study of nearly 73,000 postpartum people across 19 states and New York City between 2012 and 2019. Read the rest…

238

238

STAT

MAY 22, 2023

In 2012, the United States Preventive Services Task Force convened to determine whether it should recommend kidney disease screening for all Americans. Advocates had been pushing for it, citing ballooning rates of chronic kidney disease. But at the time, the group found there wasn’t enough evidence to say if screening was a net good.

246

246

STAT

FEBRUARY 3, 2023

The drugs, a number of so-called modulators approved starting in 2012, have been one of the great biotech success stories. Continue to STAT+ to read the full story…

Drug Development 230

Drug Development 230

STAT

MAY 4, 2023

Between 2012 and 2021, 14% of roughly 19,000 patent applications did not disclose financial support from the NIH or did not do so as required by federal law. And a new analysis finds a key reason may be most institutions and researchers that receive NIH support fail to fully or correctly disclose this information when applying for patents.

Drug Development 222

Drug Development Drug Pricing 222

STAT

OCTOBER 2, 2023

” That train of thought — calculating risks, eliminating threats — eventually led her to a job with the Food and Drug Administration in 2012 as a public health analyst. And I thought, doesn’t that mean nobody should really be sliding down poles?”

Hospitals 299

Hospitals 299

STAT

MAY 9, 2023

In 2012, Ranbaxy paid a $350 million fine to U.S. As a result, the company has halted exports from the plant to the United States. At issue is a facility Sun bought eight years ago from Ranbaxy Laboratories, which was a poster child for lax manufacturing standards in India.

196

196

STAT

NOVEMBER 3, 2022

The original guidelines , issued in 2016, helped further drive down opioid prescribing levels that had been in decline since 2012, as the country grappled with its legacy of overprescribing that contributed to the overdose epidemic.

252

252

The Guardian - Pharmaceutical Industry

MARCH 10, 2024

The latest award brings to £137m the amount he has earned since joining in 2012. a year earlier. While it drew the anger of corporate governance experts, Soriot’s generous payout was just a fraction of the sums his counterparts at the biggest US companies take home.

Packaging 130

Packaging 130

STAT

JUNE 28, 2023

He saw her over a decade ago, when the country was facing a different methotrexate shortage back in 2012. But Unguru didn’t see this particular patient recently or even in the last year. Continue to STAT+ to read the full story…

Chemotherapy 240

Chemotherapy Hospitals Drug Pricing 240

STAT

APRIL 1, 2024

Since taking the helm in 2012, Soriot has turned AstraZeneca into the second-largest company on the FTSE 100 index and last year received £16.9 … AstraZeneca’s plan to pay chief executive officer Pascal Soriot up to £18.7 and European peers.

215

215

STAT

AUGUST 15, 2023

One study found that, of nearly 40,000 patients who received a surgery to treat ischemic stroke from 2012 to 2017, close to half required inter-hospital transfer.

Hospitals 217

Hospitals 217

Pharmacy Joe

MARCH 27, 2024

This meant that any unchanged guidance statements from the 2012 9th edition were still considered to be part of the guidelines, but were not reprinted in the 2016 document. These 5 statements and their rationale for deletion are as follows: From 2012: Statement 2.5.2

Documentation 98

Documentation Inpatient 98

ALiEM - Pharm Pearls

SEPTEMBER 1, 2023

2012 Oct;55(7):930-9. Epub 2012 Jun 19. Cheng NC, Yu YC, Tai HC, Hsueh PR, Chang SC, Lai SY, Yi WC, Fang CT. Recent trend of necrotizing fasciitis in Taiwan: focus on monomicrobial Klebsiella pneumoniae necrotizing fasciitis. Clin Infect Dis. doi: 10.1093/cid/cis565. PMID: 22715175.

Diabetes 156

Diabetes Hospitals 156

The Pharmacist

DECEMBER 11, 2023

These are stark warnings featured in today’s UKHSA report on the effects of climate change – the first of its kind since 2012. Heat-related deaths are estimated to increase by one and a half times in the 2030s, while mosquito-borne diseases are also likely to come to the UK in the ‘near future’.

Vaccines 91

Vaccines 91

The Pharmacist

AUGUST 15, 2023

Mr Hunt, who was the Secretary of State for Health and Social Care between 2012 and 2018, has added his name to two local petitions against the potential closure of a Boots pharmacy […] The post Chancellor and former health secretary protests local pharmacy closure appeared first on The Pharmacist.

97

97

The Guardian - Pharmaceutical Industry

FEBRUARY 20, 2024

Soriot, who has made nearly £120m in the decade since he took the helm at the drugmaker in October 2012 , was paid £16.9m last year, including salary, benefits and bonuses, up from £15.3m the year before, according to AstraZeneca’s annual report. Continue reading.

Packaging 74

Packaging 74

STAT

MAY 26, 2023

From 2012-2018, for example, Hispanic people comprised just 9% of participants in NIH-funded studies yet make up approximately 20% of the U.S. population. Continue to STAT+ to read the full story…

193

193

STAT

AUGUST 10, 2023

trillion from 2012 to 2021, according to the Association for Accessible Medicines, a trade group representing generic drug manufacturers. That’s 23 percent more than the country’s overall inflation rate during the same period. Meanwhile, generic drug companies saved the U.S. roughly $2.6

Pharmaceutical Companies 189

Pharmaceutical Companies Pharmaceutical Companies 189

PharmaTech

JANUARY 11, 2024

Since 2012, we’ve been the industry leader in custom mRNA synthesis for research and clinical applications. Want to increase the probability success for your discovery mRNA program? Partner with TriLink BioTechnologies®. Read on to see how TriLink® is determined to deliver you success.

52

52

PhRMA

DECEMBER 15, 2022

In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.

Hospitals 114

Hospitals Physician Offices 114

ALiEM - Pharm Pearls

JANUARY 8, 2024

2012 Jul;51(7):1278-84. Epub 2012 Feb 29. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford). doi: 10.1093/rheumatology/ker518. PMID: 22378718. Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.

Hospitals 148

Hospitals 148

The Guardian - Pharmaceutical Industry

JANUARY 19, 2023

Hody Childress, a farmer and US air force veteran, began his anonymous charitable campaign when he walked into a drug store in his home town of Geraldine in 2012 and learned from the owner that sometimes families can’t afford to pay for their medicines. Continue reading.

98

98

ALiEM - Pharm Pearls

OCTOBER 16, 2023

2012 Oct;12(10):808-15. Epub 2012 May 25. Treatment includes parenteral antibiotics and prompt consultation of medical and surgical subspecialists to identify the infectious source as well as mitigate against systemic spread and/or thrombus propagation. References Kuppalli K, Livorsi D, Talati NJ, Osborn M. Lancet Infect Dis.

Hospitals 148

Hospitals 148

RX Note

APRIL 5, 2024

A 2012 systematic review of randomized trials that included trials assessing olive oil; cocoa butter; a product containing hyaluronic acid, vitamins A and E, allantoin, and calcium pantothenate; a product containing C.

Mayo Clinic 52

Mayo Clinic 52

ALiEM - Pharm Pearls

MARCH 1, 2024

link] Published November 19, 2012. In: Knoop KJ, Stack LB, Storrow AB, Thurman R. The Atlas of Emergency Medicine, 5e. McGraw Hill; 2021. link] Gurwood AS. Cut at the root. Review of Optometry. Accessed January 2023.

Hospitals 148

Hospitals 148

The Pharmacist

MARCH 21, 2023

Yesterday, the government published the results of its consultation into OPD and announced its intention to amend the Human Medicines Regulations 2012 to allow OPD at the pharmacist’s […] The post OPD won’t take effect in England until reimbursement resolved appeared first on The Pharmacist.

52

52

RX Note

NOVEMBER 4, 2023

A 2012 systematic review of case reports and case series concluded that using certain homeopathic products (such as those containing heavy metals like mercury or iron that are not highly diluted) or replacing an effective conventional treatment with an ineffective homeopathic one can cause adverse effects, some of which may be serious.

Labelling 52

Labelling Community Pharmacies 52

STAT

OCTOBER 18, 2023

since 2012, and coverage of it has continued to rise in recent years — 36% of those who could benefit from PrEP were prescribed it last year. Expanding PrEP use is a key part of a CDC program to end the HIV epidemic in the U.S. and reduce HIV infections in the country by 90% by 2030. PrEP has been available in the U.S.

Drug Pricing 247

Drug Pricing 247

Big Molecule Watch

APRIL 22, 2024

According to the intervenor complaint , “[f]rom 2012 to 2021, Regeneron’s credit card fee reimbursements for Eylea purchases exceeded $250 million to just one of its several distributors.

Drug Pricing 62

Drug Pricing 62

The Guardian - Pharmaceutical Industry

JULY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) said it had taken “immediate” action under regulation 28 of the Human Medicines Regulations 2012 law “where it appears to the MHRA that in the interests of safety the licence should be suspended”. Continue reading.

Chemotherapy 50

Chemotherapy 50

RX Note

MARCH 31, 2023

External Links Perceptions and Attitudes of People with Disabilities and Older Adults about Child-resistant Drug Packaging, 2012 Are child safety caps enough to keep kids out?, Limitations Child-resistant packaging can present difficulties for some aged individuals or people with disabilities.

Packaging 52

Packaging 52

European Pharmaceutical Review

FEBRUARY 29, 2024

and Genmab A/S made an agreement in August 2012, in which Janssen would be granted an exclusive license to develop, manufacture and commercialise daratumumab. ” The Janssen Pharmaceutical Companies of Johnson & Johnson noted that Janssen Biotech, Inc.

Documentation 98

Documentation Pharmaceutical Companies Pharmaceutical Companies 98

Pharma Marketing Network

JULY 17, 2023

Anna was named a Top 100 PharmaVoice “most inspiring leader” in 2012. With Anna at the helm, MedEvoke has quickly become a leading partner to many top-20 pharmaceutical corporations.

52

52

Pharmacy Times

AUGUST 17, 2022

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

49

49